Bone fractures more likely in an HIV-positive cohort than in the general US population: HOPS study

Derek Thaczuk, Michael Carter
Published: 25 February 2010

Between the years 2000 and 2008, 4% of HIV-positive patients in the US HIV Outpatient Study experienced bone fractures – a significantly higher rate than that estimated in the general US population. The findings were presented by lead investigator Christine Dao of the Centres for Disease Control at a Thursday session of the17th Conference on Retroviruses and Opportunistic Infections (CROI).

This study investigated the incidence rates and types of bone fracture amongst patients in the HIV Outpatient Study (HOPS) – a prospective cohort study enrolling HIV-positive patients at ten clinics in eight US cities.

Data on reported fractures were taken from the medical records of 5826 patients from the years 2000 to 2008 (only first fractures were considered). The study patients had a median age of 40 and were 79% male, 52% white, 33% black and 73% antiretroviral therapy (ART)-experienced, with a median CD4 cell count of 372 cells/mm3).

During the interval from 2000 to 2008, fractures occurred in 236 (4%) of the study patients. On average, patients with fractures were slightly older (median 45 years) and about half were ART-experienced (55%)

To compare bone fractures in HOPS to those in the general US population, the study investigators approximated the overall national rates with data from the National Hospital Ambulatory Medical Care Survey (NHAMCS), which were weighted to produce national estimates from a sample of outpatient departments around the US.

In 2006, the frequency of all fractures among adults aged 25 to 54 years was greater among HOPS participants than in the US general population (as estimated using the NHAMCS), with 84.2 and 35.6 fractures per 10,000 people occurring in each respectively, adjusted for sex.

The investigators then examined the factors associated with an increased risk of fracture in HIV-positive patients seen between 2002 and 2008. Risk factors included:

  • age 47 years or more (adjusted hazard ratio [aHR] = 1.6 compared to age 35 or less, 95% confidence interval [CI],1.0–2.5),
  • lowest-ever (nadir) CD4 cell count below 200 cells/mm3 aHR = 1.6, 95% CI, 1.1–2.3),
  • co-infection with hepatitis C virus (aHR = 1.6, 95% CI, 1.1–2.3),
  • diabetes (aHR = 1.6, 95% CI, 1.1–2.6), and
  • substance abuse (aHR = 1.5, 95% CI, 1.0–2.6).

In conclusion, the investigators found that rates of bone fracture were higher in the HOPS cohort of HIV-positive patients than in adults presenting for outpatient care in the general US population, and that rates in HOPS appeared to be increasing. Further studies were suggested to directly compare HIV-positive patients to HIV-negative controls, to assess how HIV infection and HIV treatment affect risk of fracture, and to explore how bone density loss and bone fracture risk are related in individuals with HIV.

Reference

Dao C et al. Higher and increasing rates of fracture among HIV-infected persons in the HIV Outpatient Study compared to the general US population, 1994 to 2008. 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, abstract 128, 2010.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.